Prosecution Insights
Last updated: April 19, 2026

Centro De Ingeniería Genética Y Biotecnología

5 pending office actions

Portfolio Summary

5
Total Pending OAs
1
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18269231 PEPTIDES FOR THE TREATMENT OF RESPIRATORY INFECTIONS OF VIRAL ORIGIN BOWLES, DAVID PAUL 1654 Non-Final OA Jun 22, 2023
18268118 USE OF SYNTHETIC PEPTIDE FOR THE INDUCTION OF ANTITUMOR AND ANTIVIRAL IMMUNITY GOTFREDSON, GAREN 1619 Non-Final OA Jun 16, 2023
18033035 CHIMERIC ANTIGEN COMPRISING THE EXTRACELLULAR DOMAIN OF PD-L1 CHANDRA, GYAN 1674 Non-Final OA Apr 20, 2023
17918299 PEPTIDE FOR THE TREATMENT OF CYTOKINE STORM SYNDROME BUNNER, BRIDGET E 1647 Final Rejection Oct 11, 2022
17788833 POLYPEPTIDES COMPRISING MUTATED FORMS OF HUMAN VEGF-A WITH REARRANGEMENTS OF DISULFIDE BONDS AND COMPOSITIONS CONTAINING SAME JUEDES, AMY E 1644 Non-Final OA Jun 24, 2022

Managing Centro De Ingeniería Genética Y Biotecnología's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month